Vedolızumab ELISA (mAb-based)

Enzyme immunoassay for the specific and quantitative determination of free Vedolizumab (Entyvio®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Vedolizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Reference: IG-AB116

Barcode: 8682754930349

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:


Related Documents

Quality Control Certificates

Entyvio® is a trademark of Takeda Pharmaceuticals Inc.

Required Volume (µL) 10
Incubation Time (min) 105
Sample Serum or Plasma
Package Size 96 Tests
Sensitivity (ng/mL, 10x) 0-1000
Detection Limit (ng/mL) 2
Spike Recovery (%) >95
Shelf Life (years) 2